Introduction
Migratory trophoblast undergoes a radical alteration in its repertoire of adhesion molecules as it escapes from the villous placenta and colonises maternal decidua (Figure 1a ), spiral arteries and myometrium.
Following the discovery that the expression of adhesion 20 molecules by extravillous trophoblast (EVT) is dysregulated in pathological pregnancy, interest in this area of research has intensified. Nonetheless, data from functional studies are scarce, reflecting the limitations of current in vitro culture models.
In the following review we summarise current knowledge of adhesion systems in extravillous trophoblast.
Further information on the cell biology of placental development and trophoblast invasion 25
can be found elsewhere [1, 2] .
Integrins
A plethora of studies carried out over the past twenty years has documented the expression of integrin subunits in villous and extravillous trophoblast, and described the integrin switch 30 that characterizes acquisition of an invasive phenotype, as trophoblasts differentiate, detach and invade the decidua (Figure 1a ). Cells in the columns upregulate the fibronectin receptor integrin α5β1 [3] [4] [5] [6] [7] [8] [9] [10] [11] , the fibronectin, VCAM-1 and EMILIN-1 receptor α4β1 [12], αVβ3 [12] , which binds fibronectin and other RGD-containing ligands in extracellular matrix (ECM), the laminin/collagen receptor α1β1 and the laminin receptor α6β1. They exhibit a reciprocal loss 35 of expression of the laminin receptor α6β4 [4, 6, [13] [14] [15] [16] .
Functional studies examining the role of integrins in mediating invasion of primary cytotrophoblasts (CTB) through a basement membrane-like matrix (Matrigel) and interstitial collagen have demonstrated the importance of αvβ3 and α1β1 in promoting migration and of α5β1 in anchorage [5, 6, 8, 12] . Function-blocking antibodies raised against β1 disturb 40 anchorage and reduce column outgrowth when applied to villous explants, and shift the balance of interactions away from cell-matrix and towards cell-cell adhesion [8] . Antibodies against laminin, collagen IV or integrin α1 inhibit invasion in vitro, implicating a role for the α1β1laminin or α1β1-collagen IV interactions. Conditions of reduced trophoblast invasion have also been observed when α1β1 expression is either maintained (but combined with an 45 altered protease profile, as in vitro after TNFα treatment [13] ) or reduced (as in vitro under hypoxia [14] ).
Initially, within and nearby the cell columns, CTB interacts with a type of provisional ECM known as matrix-type fibrinoid (Figure 2a , b) that contains fibronectin [17] , the ligand 50 for integrin α5β1, and vitronectin, which ligates αvβ3, as well as the basement membrane ligands laminin and collagen IV which bind α1β1. Fibrinoid accumulates between the cells and at the periphery of columns and probably anchors the columns to the maternal surface [18] . Decidual ECM is also enriched in laminins, collagen IV [19, 20] and fibronectin [19, 21] . Interaction of CTB with the stromal and vascular wall fibrillar component EMILIN- 1 55 occurs by binding to integrin α4β1, leading to haptotactic migration and upregulation of matrix metalloproteinase (MMP) activity [22] .
The effect of hypoxia on integrin expression in EVT has received attention as a potential mediator of altered depth of trophoblast invasion in preeclampsia (see below). EVT outgrowths from first trimester placental explants cultured on ECM substrates at 2%, 3%, 60 8% or 20% oxygen [8, 23, 24] express integrin α5β1, indicating that an EVT differentiation programme is initiated as cells contact the ECM. In some studies, integrin α1 upregulation has been reported not to occur at 2% oxygen, correlating with a lower migratory activity in Matrigel [14, 25] . It has been suggested that this effect on integrin α1 is controlled by HIF1α [24] . These data suggest that hypoxia permits initiation, but not completion of the normal 65 integrin switching program.
Decreased integrin α1 expression and reduced invasion is also noted when vascular endothelial growth factor (VEGF), signaling through VEGF receptor-1 (VEGF-R1) or VEGFR-3, is inhibited in primary first trimester CTB by a VEGFR-Fc fusion protein [26] . As VEGFR-1 and R-3 are highly expressed in the distal cell column and in interstitial EVT during the first 70 and second trimesters, with R-3 expression also prominent in endovascular trophoblast [26] , it is conceivable that trophoblast-derived VEGF may promote invasion in an autocrine manner by enhancing α1-mediated migration.
Insulin-like growth factors stimulate trophoblast migration [27] , and the insulin-like growth factor binding protein-1 (IGFBP-1), a secretory product of decidual cells, may 75 independently modulate trophoblast invasion in the placental bed. IGFBP-1 contains an RGD sequence motif that binds α5β1 and disrupts trophoblast binding to fibronectin, resulting in enhanced migration in vitro [15] . CD9, a tetraspanin glycoprotein whose expression in the placenta is associated with α3 and α5 integrins, may also mediate trophoblast adhesion [28] . CD9 is absent from villous CTB, but is upregulated in cell columns and is highly 80 expressed by EVT.
The presence of fibronectin molecules bearing a unique glycopeptide domain (termed oncofetal fibronectin or onfFN) within the type III connecting segment, has been noted within the placental bed. Immunohistochemical analysis has revealed the presence of onfFN in the extracellular matrix that connects extravillous anchoring trophoblasts and trophoblast 85 cell columns to the uterine wall [21] , and cell culture studies have confirmed that EVT produce and secrete onfFN in vitro [8, 21, 29] . However, not all cells in EVT subpopulations produce onfFN to the same extent. A subset of invasive EVT expressing α6 integrin and HLA-G produce high levels of gelatinases but secrete little onfFN, whereas EVT cells that express α5 integrin secrete low levels of gelatinases, produce large amounts of onfFN and 90 show reduced invasion [30] . This suggests that alterations in invasive phenotype that lead to enhanced onfFN production may result in autocrine regulation of trophoblast adhesion.
Transforming growth factor-β1 (TGF-β1) has been shown to stimulate onfFN production by trophoblast [29] , suggesting that local gradients of exogenous cytokines within the placental bed could modulate trophoblast adhesion in defined locations. Further discussion can be 95 found in a recent review [31] . αvβ3/β5 and β1 integrins mediate adhesion of human CTB to endothelial cells in vitro, suggesting that they may facilitate endovascular trophoblast adhesion and migration within uterine arteries [32] . CTB expressing α4 integrin bind the vascular cell adhesion molecule VCAM-1, indicating that α4β1 may mediate CTB-endothelium or CTB-CTB 100 interactions during endovascular invasion [12] . Macaque CTB similarly express αvβ3 and β1 integrins, and upregulate β1 in response to shear stress or co-culture with uterine microvascular endothelial cells [16, 33, 34] . Migration of macaque CTB toward vitronectin, and adhesion of CTB to myometrial endothelial cells in co-culture is mediated by integrin αvβ3/ β5. 105
The serious pregnancy complication of pre-eclampsia is characterised by shallow interstitial EVT invasion, reduced endovascular invasion and an absence of remodelling in myometrial artery segments. Decreased invasion has been attributed to the failure of differentiating CTB to adopt an invasive phenotype: trophoblasts emigrating from cell columns show persistence of integrin α6β4 expression and fail to upregulate αvβ3 and α1β1 110 [7, 35, 36] . These findings suggest that pre-eclampsia is associated with failure or delay of a CTB differentiation programme, with retention of cell adhesion molecules that under normal conditions are only expressed by villous progenitor cells and CTB in the proximal region of the cell column. However, another study has reported that expression of β1 integrins in trophoblast is similar in healthy women and women with pre-eclampsia or pre-115 term labour [37] . Some heterogeneity in the expression of different integrin α subunits was noted, with variation being observed in each study group. Simultaneous expression of α1, α3, α5 and α6 integrins may be important for migration of EVT [38] . Atypical integrin expression has also been described in ectopic pregnancy: EVT have been reported to display prominent expression of α6 and β4 subunits, despite exhibiting invasive behaviour [38] . 120 6
Immunoglobulin family cell adhesion molecules (CAMs)
Neural cell adhesion molecule (NCAM; CD56) is a cell surface glycoprotein that 125 mediates homophilic binding.
Human endovascular trophoblasts express a unique polysialylated form of NCAM which may moderate the strength of trophoblast interactions [39] . NCAM expression has been observed in trophoblast plugs within the spiral arteries but is absent from villous CTB, syncytiotrophoblast (STB) and cell columns. A similar distribution of NCAM has been noted in the macaque: endovascular and perivascular 130 trophoblast stain for NCAM, but intramural trophoblast exhibit little immunoreactivity [40] .
These findings suggest that NCAM is necessary for endovascular invasion, aiding binding of trophoblast to the arterial endothelium or to vascular extracellular matrix components.
Platelet-endothelial cell adhesion molecule-1 (PECAM-1; CD31) [41] is an immunoglobulin superfamily member that acts as both a heterophilic and homophilic 135 adhesion molecule and may mediate the attachment of trophoblast to the vascular endothelium.
Its proposed ligands include integrin αvβ3 [41] . Like NCAM, PECAM-1 expression has been described in human perivascular and endovascular trophoblasts [12, 42, 43] , but also in interstitial EVT and in CTB of the distal column [36] . However, these findings have been disputed by other groups, who observed PECAM-1 expression exclusively 140 in spiral artery endothelium throughout gestation and not in villous or extravillous trophoblast [44, 45] . It has been reported that PECAM-1 upregulation by endovascular trophoblast fails in pre-eclampsia [12], although other studies have shown no difference in its expression between normotensive and pre-eclamptic pregnancies [44, 45] . Interestingly, PECAM-1 is expressed by endovascular trophoblasts in healthy rats as well as in a rat model 145 of pre-eclampsia [46] , and PECAM-1 expression is upregulated at points of contact between CTB and endothelial cells in vitro [42, 43] . PECAM-1 is also expressed in endovascular trophoblasts and vascular endothelial cells of the macaque, although expression is often reduced in EVT distal to the arterial lumen. The spiral artery endothelium is observed to retain PECAM-1 reactivity even after vessel remodelling [47] . Since PECAM-1 plays a role in 150 transendothelial migration of leukocytes [41] , it is possible that it may function in trophoblast invasion, as cells cross either from the vessel lumen to the wall, or in the reverse direction.
Melanoma cell adhesion molecule (Mel-CAM; MUC18; CD164) is an adhesion molecule that mediates heterophilic binding to an unidentified ligand and has been shown to be 155 important in tumor progression. Mel-CAM is expressed by the majority of EVT, is present on endothelial and myometrial cells but is absent from villous CTB and STB [48, 49] . It is present on invasive trophoblast in the mouse, where antibody-mediated blockade leads to pregnancy failure [50] . Cell culture studies have demonstrated the presence of a putative
Mel-CAM ligand on uterine smooth muscle cells and have shown that disruption of Mel-CAM 160
binding promotes migration of an EVT cell line [51] .
Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1
(VCAM-1) are other members of the immunoglobulin superfamily that mediate adhesion of leukocytes to the vascular endothelium. ICAM-1 is expressed by vascular endothelial cells throughout the decidua; however, expression of VCAM-1 is variable at the implantation site 165
and it is only seen in vascular endothelial cells in the decidua basalis [39] . VCAM-1 is expressed by CTB in the distal portion of the cell column, and by both interstitial and endovascular EVT [36] . In common with the failure to alter their integrin repertoire, invasive CTB from pregnancies complicated with pre-eclampsia do not upregulate VCAM-1
expression. 170
There has been some speculation that ICAM-1, VCAM-1 and PECAM-1 may mediate adhesion of endovascular trophoblasts to the walls of spiral arteries. Studies of early gestation macaque trophoblast have shown that ICAM-1-blocking antibodies reduce transendothelial migration in vitro [52] . The same study demonstrated that antibodies against the mucin MUC-1, which is expressed by macaque endovascular EVT, reduced 175 adhesion of isolated trophoblast to uterine endothelial cells and inhibited trophoblast transendothelial migration. These data predict that both ICAM-1 and MUC-1 may be mediators of mural invasion in human pregnancy. It should be noted that MUC-1 antibodies mark a subset of human interstitial EVTs, suggesting that the EVT population contains cells that vary in their potential to colonise vessels [53] . 180
Selectins
Selectins are a family of single-chain transmembrane glycoproteins that bind oligosaccharides and permit transient tethering and shear stress-dependent rolling. Both Eand P-selectin are expressed by human vascular endothelial cells in the decidua basalis, but 185 are absent from the vessels of the decidua parietalis [39] . Thus they may be candidates for mediating endovascular trophoblast invasion/migration. Indeed, adhesion of isolated CTB to endothelial cells in vitro is partially blocked by antibodies to P-selectin [32] . In contrast, Lselectin is expressed by CTB in columns, with high expression noted at the distal ends [54] [55] [56] . L-selectin is also strongly expressed by EVT and may be important for establishing and 190 maintaining column architecture, based on the observation that function-perturbing antibodies inhibit column formation in vitro [55] .
Cadherins

VE-cadherin (VE-cad), a marker of the endothelial cell lineage, is absent from villous CTB 195
but is expressed by trophoblast cell columns, interstitial EVT and spiral artery endothelial cells [12, 36, 38] . Following loss of the vascular endothelium during arterial remodelling, VE-cad expression is further upregulated in endovascular and mural CTB, reflecting their acquisition of certain features of the endothelial phenotype [12, 42] . Antibodies to VE-cad reduce CTB adhesion, migration and invasion across Matrigel barriers in vitro, suggesting a 200 role in interaction with extracellular matrix [12, 42] . VE-cad expression is also required for first trimester trophoblast cells to bind to decidual endothelial cells in vitro [36] , and failure of invasive CTB to upregulate VE-cad expression is noted in pre-eclampsia [12, 36, 57] .
In contrast to VE-cad, E-cadherin (E-cad) expression is observed throughout anchoring villi, with cells detaching from the distal ends of columns and individual interstitial 205 EVT exhibiting reduced, discontinuous expression [57] . When present in aggregates, interstitial, intraluminal, perivascular and endovascular EVT express E-cad, although discontinuous membrane expression is observed in lone cells [58] . Isolated CTB cultured on basement membrane-like ECM express E-cad, and anti-E-cad antibodies enhance CTB invasion [12], suggesting a role in CTB-CTB attachment. Invasive CTB in pre-eclamptic 210 placentas have been shown to retain expression of E-cad [35] .
Cadherin-11 (Cad-11) expression has been documented in EVT where it is located at the tips of cell columns [59] . Although little work has been done to elucidate its role, Cad-11 may be important in promoting adhesion of trophoblast to maternal stromal cells, where it is upregulated during decidualization [60] . Similarly, expression of dysadherin, a cell 215 surface glycoprotein thought to reduce cell-cell adhesion and increase motility, is increased in CTB developing into columns [61, 62] . Dysadherin is believed to promote cell migration via effects on the actin cytoskeleton and downregulation of E-cadherin expression [57, 58] . 
Kisspeptins
Ephrins
The receptor tyrosine kinase EPHB4 and its ligands ephrin-B1 and ephrin-B2 may play a role 235 in trophoblast adhesion. In early gestation, ephrin-B1 is expressed by interstitial and endovascular EVT, and ephrin-B2 expression is observed in both villous CTB and EVT [61, 62] . Studies of EVT differentiation have revealed that acquisition of an invasive phenotype is associated with a rapid decrease in EPHB4 expression and enhanced expression of ephrin-B1 and -B2. Indeed, during differentiation of villous CTB at the proximal region of the cell 240 column, EPHB4 expression is downregulated in favour of enhanced expression of ephrin B1.
As substrates containing an EPHB4-Fc fusion protein decrease adhesion and reduce migration of CTB in vitro, and EPHB4 is expressed by the uterine venous endothelium, this may explain why EVT do not colonize the uterine veins. Conversely, ephrin B2-Fc fusion proteins support CTB migration in vitro, thus expression of ephrin-B2 by the spiral artery 245 endothelium may promote preferential arterial remodelling.
Junctional proteins
Within the anchoring column, CTB are linked by desmosomes which are associated with extensive arrays of cytoplasmic intermediate filaments (Figure 1b) [67, 68] . The tight 250 junctional proteins occludin and zona occludens-1 (ZO-1) are also present, but it is not yet clear what functional contribution they may make [69] .
Sometimes arrays of fine submembranous filaments are visible at cell interfaces (Figure 1c ). Emigration of CTB from the column (Figure 1a ) is concomitant with fracture and loss of desmosomes (Figure 2a ) and loss of ZO-1 and occludin [69, 70] . Similarly, connexin 40-containing gap junctions ( Figure  255 2b) are decreased during differentiation of CTB into a more invasive phenotype [66] .
Downregulation of connexin 40, or experimental inhibition of gap junction function, are both associated with differentiation and an increase in expression of α1 integrin [70, 71] . Cell contact, and the signalling events that follow downstream, play a profound role in the control of proliferation, death, migration and invasion in the uterine environment. A 275 better understanding of trophoblast migration and the regulation of the molecular switches that make it possible will be critical in addressing pathologies of pregnancy including preeclampsia [72] [73] [74] , preterm labour [75] , late miscarriage [76] , hypertension, [77] and IUGR [74, 78] , in which trophoblast migration and maternal vascular remodelling are impaired. 280 
Figure legends
